Here’s why the Stock of Brickell Biotech, Inc. (BBI) Stock Showed a Decline in the Premarket
Brickell Biotech, Inc. (BBI) is a biopharmaceutical company focused on the development of innovative and differentiated prescription therapeutics. The aim is to develop novel therapeutics